Ikena Oncology

About:

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Website: https://ikenaoncology.com

Twitter/X: ikenaoncology

Top Investors: OrbiMed, Fidelity, Bristol-Myers Squibb, Invus, Biotechnology Value Fund

Description:

Ikena Oncology discovers and develops biomarker-driven therapies for cancer patients. The company focuses on developing novel cancer therapies that drive the formation and spread of cancer. Ikena Oncology provides medical needs by discovering chemistry, translational science, and patient-centric drug development.